These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 3699565

  • 1. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC, Murphy GM, Dowling RH.
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [Abstract] [Full Text] [Related]

  • 2. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A, Northfield TC.
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [Abstract] [Full Text] [Related]

  • 3. Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones.
    Howard PJ, Gleeson D, Murphy GM, Dowling RH.
    Gut; 1989 Jan; 30(1):97-103. PubMed ID: 2920932
    [Abstract] [Full Text] [Related]

  • 4. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
    Iser JH, Maton PN, Murphy GM, Dowling RH.
    Br Med J; 1978 Jun 10; 1(6126):1509-12. PubMed ID: 656777
    [Abstract] [Full Text] [Related]

  • 5. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S, Ahlberg J, Angelin B, Reihnér E, Einarsson K.
    Gut; 1991 Dec 10; 32(12):1554-7. PubMed ID: 1773966
    [Abstract] [Full Text] [Related]

  • 6. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC, Hofmann AF.
    Gut; 1975 Jan 10; 16(1):1-11. PubMed ID: 806491
    [Abstract] [Full Text] [Related]

  • 7. Effects of dietary sucrose on factors influencing cholesterol gall stone formation.
    Werner D, Emmett PM, Heaton KW.
    Gut; 1984 Mar 10; 25(3):269-74. PubMed ID: 6698443
    [Abstract] [Full Text] [Related]

  • 8. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K, Chijiiwa K.
    Gut; 1993 May 10; 34(5):702-7. PubMed ID: 8504975
    [Abstract] [Full Text] [Related]

  • 9. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
    Noshiro H, Chijiiwa K, Makino I, Nakano K, Hirota I.
    Gut; 1995 Jan 10; 36(1):121-5. PubMed ID: 7890215
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G, Bazzoli F, Festi D, Ronchi M, Aldini R, Roda A, Grigolo B, Simoni P, Villanova N, Roda E.
    Gastroenterology; 1991 Aug 10; 101(2):490-6. PubMed ID: 2065925
    [Abstract] [Full Text] [Related]

  • 11. The effects of phenobarbital on biliary lipid metabolism in cholesterol gallstone subjects.
    Redinger RN.
    Lipids; 1979 Mar 10; 14(3):277-84. PubMed ID: 449630
    [Abstract] [Full Text] [Related]

  • 12. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
    Hussaini SH, Pereira SP, Murphy GM, Kennedy C, Wass JA, Besser GM, Dowling RH.
    Gut; 1995 Jan 10; 36(1):126-32. PubMed ID: 7890216
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
    Walters JR, Hood KA, Gleeson D, Ellul JP, Keightley A, Murphy GM, Dowling RH.
    Gut; 1992 Mar 10; 33(3):375-80. PubMed ID: 1568659
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting gall-stone dissolution rate during chenic acid therapy.
    Maudgal DP, Kupfer RM, Northfield TC.
    Gut; 1983 Jan 10; 24(1):7-10. PubMed ID: 6848433
    [Abstract] [Full Text] [Related]

  • 15. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
    Kern F, Everson GT, DeMark B, McKinley C, Showalter R, Braverman DZ, Szczepanik-Van Leeuwen P, Klein PD.
    J Lab Clin Med; 1982 Jun 10; 99(6):798-805. PubMed ID: 7077124
    [Abstract] [Full Text] [Related]

  • 16. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA, Small DM.
    J Clin Invest; 1977 May 10; 59(5):828-40. PubMed ID: 856870
    [Abstract] [Full Text] [Related]

  • 17. Effects of obesity and caloric intake on biliary lipid metabolism in man.
    Bennion LJ, Grundy SM.
    J Clin Invest; 1975 Oct 10; 56(4):996-1011. PubMed ID: 1159099
    [Abstract] [Full Text] [Related]

  • 18. Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism.
    Thornton JR, Emmett PM, Heaton KW.
    Gut; 1983 Jan 10; 24(1):2-6. PubMed ID: 6293939
    [Abstract] [Full Text] [Related]

  • 19. Diurnal variation in cholesterol saturation of gall-bladder bile.
    Kupfer RM, Northfield TC.
    Gut; 1983 Oct 10; 24(10):950-3. PubMed ID: 6684613
    [Abstract] [Full Text] [Related]

  • 20. Cholesterol gallstones and biliary lipid metabolism in the primate.
    Redinger RN, Grace DM.
    Gastroenterology; 1978 Feb 10; 74(2 Pt 1):201-4. PubMed ID: 413761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.